Tipranavir

替拉那韦

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameTipranavir
Drug Alias Name替拉纳韦ElodiusTipranavirumAptivusU-140690 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHepatic InsufficiencyHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/06/22
Country/TerritoryBahamasBelgiumCanada +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsHepatic Insufficiency

Other Information

ATC CodeJ05AE09
Related LinksWikipediaDrugBankKEGG